<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to induction immunosuppressive therapy for HLA- and ABO-compatible kidney transplantation*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to induction immunosuppressive therapy for HLA- and ABO-compatible kidney transplantation*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Approach to induction immunosuppressive therapy for HLA- and ABO-compatible kidney transplantation*</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">* Induction therapy consisting of antibody therapy plus standard immunosuppressive therapy is suggested for most patients undergoing kidney transplantation. However, clinical practice varies worldwide and induction therapy is frequently center specific; at some transplant centers in other countries, induction therapy is not routinely administered.<br/>
¶ Recipients of two-haplotype-identical, living, related donor kidneys are at very low risk for acute rejection and, therefore, antibody induction is not indicated. Recipients of a kidney transplant who have another functioning solid organ transplant are typically on long-term maintenance immunosuppression and are at increased risk of infection with lymphocyte depletion.<br/>
Δ In patients who are unable to tolerate rATG-Thymoglobulin, such as those who are hypotensive, leukopenic, and/or thrombocytopenic at the time of transplant surgery, basiliximab is an alternative option. Refer to UpToDate content on induction immunosuppressive therapy in kidney transplant recipients for details on dosing and administration.<br/>
<span class="lozenge">◊</span> In patients who are at low immunologic risk of acute rejection, either basiliximab or rATG-Thymoglobulin is a reasonable induction agent. Some experts prefer rATG-Thymoglobulin based upon data showing lower rates of biopsy-proven acute rejection at one year. Other experts prefer basiliximab based upon studies that have shown similar rates of rejection, patient and graft survival, and infection with rATG-Thymoglobulin and basiliximab in low-risk patients. The 2009 KDIGO clinical practice guidelines recommend the use of IL-2 receptor antibodies (ie, basiliximab) as first-line induction therapy in patients not at high immunologic risk. Refer to UpToDate content on induction immunosuppressive therapy in kidney transplant recipients for details on dosing and administration.</div><div id="graphicVersion">Graphic 134945 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
